Latest News From BioPharmaChem
05 June, 2018
The new migraine targeting drug received key European approval and could be fully approved for use by the end of the year.
27 June, 2018
Discovery of the properties of the metals in the brain involved in the progression of the neurodegenerative condition and could lead to more effective future therapies which combat the disease at its root.